Trading asset-backed securities are available in pharmaceutical industry

Starep Corporation announced that it has developed a new asset-backed security (ABS) to pool the underlying assets of 30 billion won in the account receivables of pharmaceutical firms.

The company said that pooling the assets allows them to be sold to general investors, a process called securitization, and allows the risk of investing in the underlying assets to be diversified because each s...